查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1629269

富血小板血浆市场，按产品类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Platelet Rich Plasma Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，富血小板血浆市场规模为6.4032亿美元，2024年至2032年复合年增长率为15.20%。

富含血小板血浆市场-市场动态

老龄化人口中骨科疾病盛行率的上升预计将推动市场的成长。

随着全球人口老化，肌肉骨骼疾病（包括骨关节炎、肌腱炎、韧带损伤和关节退化）的盛行率正在上升。这些疾病经常导致严重的疼痛和残疾，从而增加了非手术治疗替代方案的吸引力，例如富血小板血浆 (PRP) 疗法。世界卫生组织报告称，全球约有 17.1 亿人患有肌肉骨骼疾病，这是全球残疾的主要原因。值得注意的是，腰痛是 160 个国家导致残疾的主要原因。骨科疾病是全球第二大残疾来源。此外，PRP 提取和加工相关技术的进步可能为市场带来成长机会。然而，与治疗相关的高成本可能会对市场扩张带来挑战。

富血小板血浆市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 15.20% 左右的复合年增长率成长

根据产品类型细分，预计纯血小板血浆（Pure PRP）将在 2023 年占据最大市场份额

根据应用细分，骨科是 2023 年的领先细分市场

根据最终用户细分，医院是 2023 年的领先细分市场

按地区划分，北美是 2023 年的主要收入来源

富血小板血浆市场-細項分析：

全球富血小板血浆市场根据产品类型、应用、最终用户和地区进行细分。

依产品类型，市场分为三类：纯富血小板血浆（Pure PRP）、富白血球富血小板血浆（L-PRP）、富血小板纤维蛋白（PRF）等。纯富血小板血浆（Pure PRP）预计将主导市场成长。富血小板血浆（PRP）市场，特别是专注于纯富血小板血浆（Pure PRP）的细分市场，由于其在骨科、皮肤科和美容等各个医疗领域的应用不断增加而不断增长。纯PRP是指不含红血球、白血球和其他血液成分的PRP形式，含有较高浓度的血小板，负责组织癒合和再生。 PRP 分离技术取得了重大进展，可以有效提取纯 PRP。此外，富含白血球的片段由于其在普通外科、骨科和运动损伤中的实用性不断增加而具有增长的潜力。

根据应用，市场分为两个主要部分：骨科、运动医学、美容外科、皮肤科、眼科、神经外科、一般外科和其他。骨科是市场扩张的主要驱动力。骨科领域的富血小板血浆 (PRP) 市场正在大幅成长，因为它能够有效治疗各种肌肉骨骼疾病，如肌腱损伤、韧带扭伤、骨关节炎和肌肉拉伤。 PRP 疗法作为一种促进癒合和再生的非侵入性治疗方法越来越受到关注，作为传统手术方法的替代方法。此外，运动医学在 PRP 市场中发挥着至关重要的作用，因为运动员经常遇到与运动相关的伤害，包括韧带撕裂、肌肉拉伤和肌腱炎。 PRP 因其加速恢復的能力而特别受到运动员的青睐，使他们能够更快地恢復活动。

根据最终用户，市场分为两个部分：医院、诊所和其他，其中医院引领市场扩张。随着人们越来越多地接受 PRP 疗法作为各种医疗问题的非手术、微创解决方案，医院内的富血小板血浆 (PRP) 市场正在经历显着成长。 PRP 广泛用于骨科、皮肤科、疼痛管理和再生医学等治疗领域，使其成为医院环境中重要的治疗替代方案。随着医院越来越多地将PRP纳入其治疗框架，加强PRP在再生医学和其他医学专业的应用前景广阔。

富血小板血浆市场 - 地理洞察

预计北美将成为市场成长的主要驱动力，这主要归因于化妆品行业越来越多地采用富血小板血浆（PRP）。该地区是技术进步的中心，PRP 製备设备和萃取系统的改进提高了手术的有效性、安全性和可及性。护理点设备的创新促进了临床环境中更快的 PRP 製备，从而促进了 PRP 在美容治疗中的广泛应用。根据国际美容整形外科学会 (ISAPS) 的报告，美国的整容手术数量居全球领先地位，总计 7,347,900 例，占全球所有外科手术的 15.5%，占非外科手术的 30.4%。同时，由于意识的提高、PRP 治疗的普及以及对非手术美容治疗的需求不断增加，欧洲和亚太地区预计将大幅增长。此外，拉丁美洲和中东地区正在经历成长，这主要是由于 PRP 在美容应用中的日益普及以及医疗旅游在特定领域的扩张。

富含血小板血浆市场-竞争格局：

富血小板血浆 (PRP) 市场竞争激烈，其特点是许多公司提供基于 PRP 的尖端疗法和技术。旨在创建先进 PRP 系统的持续研发工作将使这些公司能够透过产品创新保持竞争优势，从而提高成果和更广泛的接受度。一些公司正在寻求收购较小的实体或建​​立策略合作伙伴关係，以加强其市场地位、取得新技术并使其产品多样化。随着对非侵入性治疗的需求持续增长，特别是在美容和骨科领域，PRP 市场内的竞争预计将加剧，成熟的全球公司和充满活力的新创公司在塑造其未来方面发挥关键作用。

最新进展：

血液管理解决方案领域的知名实体泰尔茂血液和细胞技术公司 (Terumo BCT) 在美国推出了 Reveos 自动化血液处理系统。此措施旨在协助血液中心满足血液和血小板供应的需求，同时提高其人员的营运效率。位于德州的 Carter BloodCare 正准备采用 Reveos 系统来生产用于输血的血小板、红血球和血浆。

目录

第一章：富血小板血浆市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的富血小板血浆市场片段
    • 富血小板血浆市场片段（依应用）
    • 最终用户的富血小板血浆市场片段
    • 按国家/地区分類的富血小板血浆市场摘要
    • 按地区分類的富血小板血浆市场片段
  • 竞争洞察

第 3 章：富血小板血浆主要市场趋势

  • 富血小板血浆市场驱动因素
    • 市场驱动因素的影响分析
  • 富血小板血浆市场限制
    • 市场限制影响分析
  • 富血小板血浆市场机会
  • 富血小板血浆市场未来趋势

第 4 章：富血小板血浆产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：富血小板血浆市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：富血小板血浆市场格局

  • 2023 年富血小板血浆市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：富血小板血浆市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 纯富血小板血浆（纯 PRP）
    • 富含白血球的富血小板血浆 (L-PRP)
    • 富含血小板纤维蛋白 (PRF)
    • 其他的

第 8 章：富血小板血浆市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 骨科
    • 运动医学
    • 整容手术
    • 皮肤科
    • 眼科手术
    • 神经外科
    • 一般外科
    • 其他的

第 9 章：富血小板血浆市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 其他的

第 10 章：富血小板血浆市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美富血小板血浆主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲富血小板血浆主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区富血小板血浆主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲富血小板血浆主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲富血小板血浆主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 富血小板血浆产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Johnson & Johnson Services, Inc.
    • Arthrex, Inc.
    • EmCyte Corporation
    • Dr PRP USA LLC
    • Juventix Regenerative Medical, LLC.
    • Terumo Corporation
    • Zimmer Biomet
    • Stryker
    • Apex Biologix
    • Celling Biosciences, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4367

REPORT HIGHLIGHT

The Platelet Rich Plasma Market size was valued at USD 640.32 million in 2023, expanding at a CAGR of 15.20% from 2024 to 2032.

Platelet-rich plasma (PRP) is a biological treatment that utilizes a patient's blood to address injuries and medical conditions. The preparation of PRP involves the centrifugation of the patient's blood, which concentrates the platelets within the plasma, the fluid component of blood. This process results in a PRP formulation that has a significantly higher platelet concentration compared to standard blood, thereby facilitating an accelerated healing process. The safety of PRP therapy is assured as it employs the patient's biological material, promoting the strengthening of bodily structures rather than their deterioration. PRP therapy finds applications across various medical disciplines, including orthopedics, sports medicine, dermatology, and aesthetic treatments. It is commonly employed to manage injuries affecting muscles, tendons, ligaments, and joints, in addition to enhancing recovery in conditions such as osteoarthritis.

Platelet-Rich Plasma Market- Market Dynamics

The rising prevalence of orthopedic conditions among the aging population is expected to drive the growth of the market.

As the global demographic shifts towards an older population, the prevalence of musculoskeletal disorders, including osteoarthritis, tendonitis, ligament injuries, and joint degeneration, is on the rise. These ailments frequently result in significant pain and disability, thereby increasing the appeal of non-surgical treatment alternatives such as Platelet-Rich Plasma (PRP) therapy. The World Health Organization reports that approximately 1.71 billion individuals worldwide suffer from musculoskeletal conditions, which are the foremost contributors to disability globally. Notably, low back pain stands out as the primary cause of disability in 160 countries. Orthopedic disorders rank as the second largest source of disability on a global scale. Additionally, advancements in the technology related to PRP extraction and processing may present growth opportunities for the market. Nevertheless, the high cost associated with treatment could pose challenges to market expansion.

Platelet Rich Plasma Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.20% over the forecast period (2024-2032)

Based on product type segmentation, Pure Platelet Rich Plasma (Pure PRP) was predicted to show maximum market share in the year 2023

Based on application segmentation, Orthopedics was the leading segment in 2023

Based on End-User segmentation, hospitals were the leading segment in 2023

Based on region, North America was the leading revenue generator in 2023

Platelet Rich Plasma Market- Segmentation Analysis:

The Global Platelet Rich Plasma Market is segmented on the basis of Product Type, Application, End-User, and Region.

The market is divided into three categories based on product type: Pure Platelet Rich Plasma (Pure PRP), Leukocyte-rich Platelet Rich Plasma (L-PRP), Platelet Rich Fibrin (PRF), and others. Pure Platelet Rich Plasma (Pure PRP) is projected to dominate market growth. The Platelet-Rich Plasma (PRP) Market, particularly the segment focused on Pure Platelet-Rich Plasma (Pure PRP), has been growing due to its increasing application in various medical fields such as orthopedics, dermatology, and aesthetics. Pure PRP refers to a form of PRP that is free from red blood cells, white blood cells, and other blood components, containing a higher concentration of platelets that are responsible for tissue healing and regeneration. There have been significant advancements in PRP separation technologies that allow for the efficient extraction of Pure PRP. Furthermore, the leucocyte-rich segment has the potential to grow due to its increasing utility across general surgery, orthopedic, and sports injuries.

The market is categorized into two main segments based on application: Orthopedics, Sports Medicine, Cosmetic Surgery, Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others. Orthopedics is the primary driver of market expansion. The Platelet-Rich Plasma (PRP) Market within orthopedics is witnessing substantial growth due to its efficacy in addressing various musculoskeletal disorders, such as tendon injuries, ligament sprains, osteoarthritis, and muscle strains. PRP therapy is gaining traction as a non-invasive treatment that fosters healing and regeneration, serving as an alternative to conventional surgical methods. Additionally, sports medicine plays a crucial role in the PRP market, as athletes frequently encounter injuries related to their sports, including torn ligaments, muscle strains, and tendinitis. PRP is especially favored by athletes for its capacity to expedite recovery, enabling them to resume their activities more swiftly.

The market is categorized into two segments based on End-User: Hospitals, Clinics, and Others, with hospitals leading the market expansion. The Platelet-Rich Plasma (PRP) Market within hospitals is experiencing notable growth, fueled by the rising acceptance of PRP therapy as a non-surgical, minimally invasive solution for various medical issues. PRP is utilized across a wide array of therapeutic fields, such as orthopedics, dermatology, pain management, and regenerative medicine, establishing it as a vital treatment alternative in hospital environments. As hospitals increasingly incorporate PRP into their treatment frameworks, there are considerable prospects for enhancing the application of PRP in regenerative medicine and other medical specialties.

Platelet Rich Plasma Market- Geographical Insights

North America is anticipated to be a key driver of market growth, primarily attributed to the increasing adoption of Platelet Rich Plasma (PRP) within the cosmetic industry. This region serves as a center for technological advancements, with improvements in PRP preparation devices and extraction systems enhancing the effectiveness, safety, and accessibility of the procedure. Innovations in point-of-care devices facilitate faster PRP preparation in clinical settings, thereby promoting the widespread application of PRP in cosmetic treatments. The United States leads globally in the number of cosmetic procedures performed, totaling 7,347,900, which accounts for 15.5% of all surgical procedures and 30.4% of non-surgical procedures worldwide, as reported by the International Society of Aesthetic Plastic Surgery (ISAPS). Meanwhile, Europe and the Asia Pacific region are projected to witness substantial growth driven by heightened awareness, improved access to PRP therapies, and an increasing demand for non-surgical aesthetic treatments. Additionally, Latin America and the Middle East are experiencing growth, largely due to the rising popularity of PRP in cosmetic applications and the expansion of medical tourism in specific areas.

Platelet-Rich Plasma Market- Competitive Landscape:

The Platelet-Rich Plasma (PRP) Market exhibits a high level of competition, characterized by a multitude of companies that provide cutting-edge PRP-based therapies and technologies. Ongoing research and development efforts aimed at creating advanced PRP systems will enable these companies to maintain a competitive edge through product innovation, resulting in enhanced outcomes and broader acceptance. Several firms are pursuing acquisitions of smaller entities or establishing strategic partnerships to strengthen their market position, access new technologies, and diversify their product offerings. As the demand for non-invasive treatments continues to grow, especially in the fields of aesthetics and orthopedics, competition within the PRP market is expected to escalate, with both established global firms and dynamic startups playing pivotal roles in shaping its future.

Recent Developments:

Terumo Blood and Cell Technologies (Terumo BCT), a prominent entity in the field of blood management solutions, has introduced the Reveos Automated Blood Processing System in the United States. This initiative aims to assist blood centers in fulfilling their requirements for blood and platelet supplies while enhancing operational efficiency for their personnel. Carter BloodCare, located in Texas, is preparing to adopt the Reveos system for the production of platelets, red blood cells, and plasma intended for transfusion.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLATELET RICH PLASMA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson Services, Inc.
  • Arthrex, Inc.
  • EmCyte Corporation
  • Dr. PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences, Inc.
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pure Platelet Rich Plasma (Pure PRP)
  • Leukocyte-rich Platelet Rich Plasma (L-PRP)
  • Platelet Rich Fibrin (PRF)
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Orthopedics
  • Sports Medicine
  • Cosmetic Surgery
  • Dermatology
  • Ophthalmic Surgery
  • Neurosurgery
  • General Surgery
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Platelet Rich Plasma Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Platelet Rich Plasma Market Snippet by Product Type
    • 2.1.2. Platelet Rich Plasma Market Snippet by Application
    • 2.1.3. Platelet Rich Plasma Market Snippet by End-User
    • 2.1.4. Platelet Rich Plasma Market Snippet by Country
    • 2.1.5. Platelet Rich Plasma Market Snippet by Region
  • 2.2. Competitive Insights

3. Platelet Rich Plasma Key Market Trends

  • 3.1. Platelet Rich Plasma Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Platelet Rich Plasma Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Platelet Rich Plasma Market Opportunities
  • 3.4. Platelet Rich Plasma Market Future Trends

4. Platelet Rich Plasma Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Platelet Rich Plasma Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Platelet Rich Plasma Market Landscape

  • 6.1. Platelet Rich Plasma Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Platelet Rich Plasma Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Pure Platelet Rich Plasma (Pure PRP)
    • 7.1.3. Leukocyte-rich Platelet Rich Plasma (L-PRP)
    • 7.1.4. Platelet Rich Fibrin (PRF)
    • 7.1.5. Others

8. Platelet Rich Plasma Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Orthopedics
    • 8.1.3. Sports Medicine
    • 8.1.4. Cosmetic Surgery
    • 8.1.5. Dermatology
    • 8.1.6. Ophthalmic Surgery
    • 8.1.7. Neurosurgery
    • 8.1.8. General Surgery
    • 8.1.9. Others

9. Platelet Rich Plasma Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Platelet Rich Plasma Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Platelet Rich Plasma Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Platelet Rich Plasma Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Platelet Rich Plasma Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Platelet Rich Plasma Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Platelet Rich Plasma Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Platelet Rich Plasma Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.2. Arthrex, Inc.
    • 11.2.3. EmCyte Corporation
    • 11.2.4. Dr PRP USA LLC
    • 11.2.5. Juventix Regenerative Medical, LLC.
    • 11.2.6. Terumo Corporation
    • 11.2.7. Zimmer Biomet
    • 11.2.8. Stryker
    • 11.2.9. Apex Biologix
    • 11.2.10. Celling Biosciences, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us